Centre Hospitalier Universitaire de Nancy - Hôpital Central

Vandœuvre-lès-Nancy 54519

1 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Urinary Bladder Neoplasms

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) — Completed